Abstract
Addition of high-dose cytarabine (HDCA) to the conventional cyclophosphamide/total-body irradiation (CY/TBI) regimen significantly improved prognosis after cord blood transplantation (CBT) for adult acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The efficacy of HDCA in bone marrow or peripheral blood stem cell transplantation (BMT/PBSCT), however, has not yet been elucidated. We conducted a cohort study to compare the prognosis of HDCA/CY/TBI (N = 435) and CY/TBI (N = 1667) in BMT/PBSCT for AML/MDS using a Japanese transplant registry database. The median age was 38 years, and 86.0% of the patients had AML. Unrelated donors comprised 54.6%, and 63.9% of donors were human leukocyte antigen (HLA)-matched. Overall survival (OS) was not improved in the HDCA/CY/TBI group (adjusted hazard ratio (HR), 1.14; p = 0.13). Neutrophil engraftment was inferior (HR, 0.80; p < 0.01), and the incidence of hemorrhagic cystitis and thrombotic microangiopathy increased in HDCA/CY/TBI (HR, 1.47 and 1.60; p = 0.06 and 0.04, respectively), leading to significantly higher non-relapse mortality (NRM; HR, 1.48; p < 0.01). Post-transplant relapse and tumor-related mortality were not suppressed by the addition of HDCA. This study ind...Continue Reading
References
Nov 9, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yoshinobu KandaUNKNOWN Japan Marrow Donor Program
Nov 23, 2006·Bone Marrow Transplantation·Y InamotoY Kodera
Jul 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michel DuvalDaniel Weisdorf
Jan 5, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Vincent T HoEdwin P Alyea
Nov 2, 2011·Blood·Junya KandaYoshinobu Kanda
Sep 5, 2012·Hematology·Yasuyuki AraiYasunori Ueda
May 15, 2013·Current Hematologic Malignancy Reports·Nicholas D Reese, Gary J Schiller
Aug 21, 2013·Current Oncology Reports·John Magenau, Daniel R Couriel
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnon NaglerMohamad Mohty
Sep 24, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yasuyuki AraiAkifumi Takaori-Kondo
Sep 26, 2013·Blood·Edward A CopelanWael Saber
Dec 10, 2013·Hematology·Koen van Besien
Apr 19, 2015·Leukemia Research·Takaaki KonumaSatoshi Takahashi
Jun 3, 2015·Blood·Yasuyuki AraiUNKNOWN AML and MDS Working Group of the Japan Society for Hematopoietic Cell Transplantation
Citations
Sep 20, 2016·Bone Marrow Transplantation·Y AraiS Mizuta
Jan 29, 2018·International Journal of Hematology·Akiyoshi Takami
Jul 5, 2016·Bone Marrow Transplantation·C-C ZhengZ-M Sun
Apr 16, 2016·Oncotarget·Li XuanQifa Liu
May 20, 2016·Journal of Hematology & Oncology·Ke Zhao, Qifa Liu
Feb 14, 2016·Journal of Hematology & Oncology·Kazuhiro IkegameHiroyasu Ogawa
Oct 23, 2016·Cell Biology and Toxicology·Xiaodan LuoHuo Tan
Apr 14, 2016·Journal of Hematology & Oncology·Ying-Jun ChangXiao-Jun Huang
May 5, 2020·Annals of Hematology·Masamitsu YanadaShingo Yano
Nov 22, 2019·Blood Advances·Yasuyuki AraiYoshiko Atsuta
Mar 20, 2021·International Journal of Hematology·Toshiro KawakitaMichihiro Hidaka
Apr 9, 2021·Transplantation and Cellular Therapy·Norihiro UedaMasamitsu Yanada
May 22, 2021·Frontiers in Cell and Developmental Biology·Stefania CrippaMaria Ester Bernardo
Jun 17, 2021·Cancer Medicine·Shigeki HirabayashiShingo Yano
Sep 14, 2021·Frontiers in Oncology·Jennifer VogelNatia Esiashvili